Gate Bioscience
A new class of small molecule therapeutics: Molecular Gates
- Headquarters
- California, California
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- gatebio.com
- Total Funding
- $125.0M
- Last Round
- $65.0M Series BNov 2025
About
Gate Bioscience creates a new class of small molecule therapeutics called Molecular Gates. Backed by a16z, Forbion, Versant. 2025 collaboration with Eli Lilly following $65M Series B.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account